This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Why “reprogramming” is the buzziest approach to reversing aging right now Earlier this week, Life Biosciences, a biotech company focused on reversing age-related diseases, announced that it had dosed its first…
The viral personal AI assistant formerly known as Clawdbot has a new shell — again. After briefly rebranding as Moltbot, it has now picked OpenClaw as its new name.
To unpack what SpaceX’s IPO chatter means, how private liquidity works before a debut, and what investors are looking for in today’s pre-IPO giants, we spoke with Greg Martin, managing director at Rainmaker Securities, a broker-dealer specializing in secondary share transactions for late-stage private companies.